Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1970
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1972 2
1973 3
1974 8
1975 5
1976 5
1977 8
1978 18
1979 14
1980 16
1981 11
1982 21
1983 23
1984 39
1985 44
1986 47
1987 42
1988 82
1989 94
1990 118
1991 88
1992 130
1993 134
1994 177
1995 155
1996 138
1997 210
1998 161
1999 184
2000 190
2001 290
2002 330
2003 331
2004 408
2005 353
2006 367
2007 353
2008 311
2009 332
2010 429
2011 440
2012 438
2013 477
2014 520
2015 551
2016 601
2017 548
2018 519
2019 434
2020 535
2021 593
2022 718
2023 706
2024 571
2025 31

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

12,395 results

Results by year

Filters applied: . Clear all
Page 1
Small-cell lung cancer.
Rudin CM, Brambilla E, Faivre-Finn C, Sage J. Rudin CM, et al. Nat Rev Dis Primers. 2021 Jan 14;7(1):3. doi: 10.1038/s41572-020-00235-0. Nat Rev Dis Primers. 2021. PMID: 33446664 Free PMC article. Review.
Small-cell lung cancer (SCLC) represents about 15% of all lung cancers and is marked by an exceptionally high proliferative rate, strong predilection for early metastasis and poor prognosis. ...The recent introduction of immune checkpoint blockade into
Small-cell lung cancer (SCLC) represents about 15% of all lung cancers and is marked by an exceptionally high pr
Lung cancer immunotherapy: progress, pitfalls, and promises.
Lahiri A, Maji A, Potdar PD, Singh N, Parikh P, Bisht B, Mukherjee A, Paul MK. Lahiri A, et al. Mol Cancer. 2023 Feb 21;22(1):40. doi: 10.1186/s12943-023-01740-y. Mol Cancer. 2023. PMID: 36810079 Free PMC article. Review.
Different tumor-specific vaccination strategies are gaining ground in the treatment of lung cancer. Recent advances in adoptive cell therapy (CAR T, TCR, TIL), the associated clinical trials on lung cancer, and associated hurdles are discussed in this review. …
Different tumor-specific vaccination strategies are gaining ground in the treatment of lung cancer. Recent advances in adoptive ce
Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions.
Megyesfalvi Z, Gay CM, Popper H, Pirker R, Ostoros G, Heeke S, Lang C, Hoetzenecker K, Schwendenwein A, Boettiger K, Bunn PA Jr, Renyi-Vamos F, Schelch K, Prosch H, Byers LA, Hirsch FR, Dome B. Megyesfalvi Z, et al. CA Cancer J Clin. 2023 Nov-Dec;73(6):620-652. doi: 10.3322/caac.21785. Epub 2023 Jun 17. CA Cancer J Clin. 2023. PMID: 37329269 Free article. Review.
Small cell lung cancer (SCLC) is characterized by rapid growth and high metastatic capacity. ...Genomic profiling of SCLC reveals genetic instability, almost universal inactivation of the tumor suppressor genes TP53 and RB1, and a high mutation burden. Becaus
Small cell lung cancer (SCLC) is characterized by rapid growth and high metastatic capacity. ...Genomic profiling of SC
Lung cancer.
Thai AA, Solomon BJ, Sequist LV, Gainor JF, Heist RS. Thai AA, et al. Lancet. 2021 Aug 7;398(10299):535-554. doi: 10.1016/S0140-6736(21)00312-3. Epub 2021 Jul 21. Lancet. 2021. PMID: 34273294 Review.
Lung cancer is one of the most frequently diagnosed cancers and the leading cause of cancer-related deaths worldwide with an estimated 2 million new cases and 1.76 million deaths per year. ...This seminar provides an overview of advances in the screening, diagnosis, and tr
Lung cancer is one of the most frequently diagnosed cancers and the leading cause of cancer-related deaths worldwide with an estimate
Advancements in small cell lung cancer.
Lee JH, Saxena A, Giaccone G. Lee JH, et al. Semin Cancer Biol. 2023 Aug;93:123-128. doi: 10.1016/j.semcancer.2023.05.008. Epub 2023 May 24. Semin Cancer Biol. 2023. PMID: 37236329 Review.
Small cell lung cancer (SCLC) is a recalcitrant cancer with an urgent need for novel therapeutics, preclinical models, and elucidation of the molecular pathways responsible for its rapid resistance. ...
Small cell lung cancer (SCLC) is a recalcitrant cancer with an urgent need for novel therapeutics, preclinical models,
Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data.
Rudin CM, Poirier JT, Byers LA, Dive C, Dowlati A, George J, Heymach JV, Johnson JE, Lehman JM, MacPherson D, Massion PP, Minna JD, Oliver TG, Quaranta V, Sage J, Thomas RK, Vakoc CR, Gazdar AF. Rudin CM, et al. Nat Rev Cancer. 2019 May;19(5):289-297. doi: 10.1038/s41568-019-0133-9. Nat Rev Cancer. 2019. PMID: 30926931 Free PMC article. Review.
Small cell lung cancer (SCLC) is an exceptionally lethal malignancy for which more effective therapies are urgently needed. Several lines of evidence, from SCLC primary human tumours, patient-derived xenografts, cancer cell lines and genetically engine
Small cell lung cancer (SCLC) is an exceptionally lethal malignancy for which more effective therapies are urgently nee
Small cell lung cancer: Novel treatments beyond immunotherapy.
Meijer JJ, Leonetti A, Airò G, Tiseo M, Rolfo C, Giovannetti E, Vahabi M. Meijer JJ, et al. Semin Cancer Biol. 2022 Nov;86(Pt 2):376-385. doi: 10.1016/j.semcancer.2022.05.004. Epub 2022 May 11. Semin Cancer Biol. 2022. PMID: 35568295 Free article. Review.
Small cell lung cancer (SCLC) arises in peribronchial locations and infiltrates the bronchial submucosa, including about 15% of lung cancer cases. ...In particular, new agents targeting DNA damage repair, cell cycle checkpoint, and apoptosis pat
Small cell lung cancer (SCLC) arises in peribronchial locations and infiltrates the bronchial submucosa, including abou
Emerging Strategies for the Treatment of Small Cell Lung Cancer: A Review.
Petty WJ, Paz-Ares L. Petty WJ, et al. JAMA Oncol. 2023 Mar 1;9(3):419-429. doi: 10.1001/jamaoncol.2022.5631. JAMA Oncol. 2023. PMID: 36520421 Review.
IMPORTANCE: Small cell lung cancer (SCLC) is an aggressive disease that is characterized by rapid growth and the early development of metastases. ...Recently, immunotherapy-based regimens have become available for the management of SCLC, with 2 programmed …
IMPORTANCE: Small cell lung cancer (SCLC) is an aggressive disease that is characterized by rapid growth and the early …
Extensive-Stage Small-Cell Lung Cancer: First-Line and Second-Line Treatment Options.
Zugazagoitia J, Paz-Ares L. Zugazagoitia J, et al. J Clin Oncol. 2022 Feb 20;40(6):671-680. doi: 10.1200/JCO.21.01881. Epub 2022 Jan 5. J Clin Oncol. 2022. PMID: 34985925 Review.
Extensive-stage small-cell lung cancer is a therapeutically challenging disease. After more than two decades without clinical progress, the addition of programmed cell death protein 1 axis blockade to platinum-based chemotherapy has demonstrated sustai …
Extensive-stage small-cell lung cancer is a therapeutically challenging disease. After more than two decades without cl …
Radiation and Systemic Therapy for Limited-Stage Small-Cell Lung Cancer.
Bogart JA, Waqar SN, Mix MD. Bogart JA, et al. J Clin Oncol. 2022 Feb 20;40(6):661-670. doi: 10.1200/JCO.21.01639. Epub 2022 Jan 5. J Clin Oncol. 2022. PMID: 34985935 Free PMC article. Review.
Progress in the overall treatment of small-cell lung cancer (SCLC) has moved at a slower pace than non-small-cell lung cancer. ...
Progress in the overall treatment of small-cell lung cancer (SCLC) has moved at a slower pace than non-small- …
12,395 results
You have reached the last available page of results. Please see the User Guide for more information.